A patient with obesity is scheduled for general anesthesia, and remimazolam induction is being considered. You are reviewing evidence comparing total body weight and lean body weight scalars for induction dosing in patients with obesity.
What does this randomized controlled trial support regarding remimazolam induction at 12 mg·kg−1·hr−1 iv?